nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—PTGS1—Bortezomib—hematologic cancer	0.0312	0.0489	CbGbCtD
Pioglitazone—PTGS1—Thalidomide—hematologic cancer	0.0272	0.0426	CbGbCtD
Pioglitazone—PTGS1—Ifosfamide—hematologic cancer	0.0239	0.0375	CbGbCtD
Pioglitazone—PTGS1—Imatinib—hematologic cancer	0.0229	0.0358	CbGbCtD
Pioglitazone—CYP2C9—Bexarotene—hematologic cancer	0.0205	0.0321	CbGbCtD
Pioglitazone—SLCO1B1—Irinotecan—hematologic cancer	0.0195	0.0305	CbGbCtD
Pioglitazone—CYP2C8—Bortezomib—hematologic cancer	0.018	0.0282	CbGbCtD
Pioglitazone—SLCO1B3—Methotrexate—hematologic cancer	0.0177	0.0277	CbGbCtD
Pioglitazone—CYP2D6—Lomustine—hematologic cancer	0.0174	0.0273	CbGbCtD
Pioglitazone—CYP2C9—Idarubicin—hematologic cancer	0.017	0.0266	CbGbCtD
Pioglitazone—CYP2D6—Idarubicin—hematologic cancer	0.0155	0.0243	CbGbCtD
Pioglitazone—CYP2C19—Bortezomib—hematologic cancer	0.0151	0.0237	CbGbCtD
Pioglitazone—CYP2C8—Ifosfamide—hematologic cancer	0.0138	0.0216	CbGbCtD
Pioglitazone—CYP2D6—Hydroxyurea—hematologic cancer	0.0132	0.0207	CbGbCtD
Pioglitazone—CYP2C19—Thalidomide—hematologic cancer	0.0132	0.0206	CbGbCtD
Pioglitazone—CYP2C9—Bortezomib—hematologic cancer	0.0126	0.0197	CbGbCtD
Pioglitazone—CYP2C19—Teniposide—hematologic cancer	0.0126	0.0197	CbGbCtD
Pioglitazone—CYP2C8—Nilotinib—hematologic cancer	0.012	0.0188	CbGbCtD
Pioglitazone—CYP3A4—Bexarotene—hematologic cancer	0.0119	0.0187	CbGbCtD
Pioglitazone—CYP2C19—Ifosfamide—hematologic cancer	0.0116	0.0181	CbGbCtD
Pioglitazone—CYP2D6—Bortezomib—hematologic cancer	0.0115	0.018	CbGbCtD
Pioglitazone—PTGS1—Etoposide—hematologic cancer	0.0114	0.0179	CbGbCtD
Pioglitazone—CYP3A4—Lomustine—hematologic cancer	0.0111	0.0174	CbGbCtD
Pioglitazone—CYP3A4—Busulfan—hematologic cancer	0.0111	0.0174	CbGbCtD
Pioglitazone—CYP2C19—Imatinib—hematologic cancer	0.0111	0.0173	CbGbCtD
Pioglitazone—CYP2C9—Thalidomide—hematologic cancer	0.0109	0.0171	CbGbCtD
Pioglitazone—CYP2C9—Teniposide—hematologic cancer	0.0104	0.0163	CbGbCtD
Pioglitazone—SLCO1B1—Methotrexate—hematologic cancer	0.0103	0.0161	CbGbCtD
Pioglitazone—CYP3A4—Thiotepa—hematologic cancer	0.00988	0.0155	CbGbCtD
Pioglitazone—CYP2C9—Ifosfamide—hematologic cancer	0.00964	0.0151	CbGbCtD
Pioglitazone—CYP2C9—Imatinib—hematologic cancer	0.0092	0.0144	CbGbCtD
Pioglitazone—CYP2D6—Imatinib—hematologic cancer	0.00842	0.0132	CbGbCtD
Pioglitazone—CYP2C9—Nilotinib—hematologic cancer	0.00836	0.0131	CbGbCtD
Pioglitazone—CYP3A4—Methoxsalen—hematologic cancer	0.00768	0.012	CbGbCtD
Pioglitazone—CYP2D6—Nilotinib—hematologic cancer	0.00765	0.012	CbGbCtD
Pioglitazone—CYP2D6—Vinorelbine—hematologic cancer	0.00758	0.0119	CbGbCtD
Pioglitazone—CYP3A4—Bortezomib—hematologic cancer	0.0073	0.0114	CbGbCtD
Pioglitazone—CYP2C19—Prednisone—hematologic cancer	0.00729	0.0114	CbGbCtD
Pioglitazone—CYP3A4—Daunorubicin—hematologic cancer	0.00699	0.0109	CbGbCtD
Pioglitazone—CYP2C8—Etoposide—hematologic cancer	0.0066	0.0103	CbGbCtD
Pioglitazone—CYP3A4—Cytarabine—hematologic cancer	0.00616	0.00965	CbGbCtD
Pioglitazone—CYP3A4—Teniposide—hematologic cancer	0.00607	0.00951	CbGbCtD
Pioglitazone—CYP3A4—Ifosfamide—hematologic cancer	0.0056	0.00877	CbGbCtD
Pioglitazone—CYP2C8—Dexamethasone—hematologic cancer	0.00543	0.0085	CbGbCtD
Pioglitazone—CYP3A4—Imatinib—hematologic cancer	0.00535	0.00838	CbGbCtD
Pioglitazone—CYP3A4—Ruxolitinib—hematologic cancer	0.00504	0.00789	CbGbCtD
Pioglitazone—CYP3A4—Nilotinib—hematologic cancer	0.00486	0.00762	CbGbCtD
Pioglitazone—CYP3A4—Vinorelbine—hematologic cancer	0.00482	0.00755	CbGbCtD
Pioglitazone—CYP2C9—Cisplatin—hematologic cancer	0.00469	0.00734	CbGbCtD
Pioglitazone—CYP2D6—Vinblastine—hematologic cancer	0.00467	0.00732	CbGbCtD
Pioglitazone—CYP2C19—Dexamethasone—hematologic cancer	0.00455	0.00713	CbGbCtD
Pioglitazone—CYP3A4—Triamcinolone—hematologic cancer	0.00441	0.00691	CbGbCtD
Pioglitazone—CYP3A4—Dasatinib—hematologic cancer	0.0043	0.00673	CbGbCtD
Pioglitazone—CYP3A4—Mitoxantrone—hematologic cancer	0.00425	0.00665	CbGbCtD
Pioglitazone—CYP2C9—Dexamethasone—hematologic cancer	0.00379	0.00593	CbGbCtD
Pioglitazone—CYP3A4—Betamethasone—hematologic cancer	0.00378	0.00593	CbGbCtD
Pioglitazone—CYP3A4—Prednisolone—hematologic cancer	0.00373	0.00585	CbGbCtD
Pioglitazone—CYP3A4—Prednisone—hematologic cancer	0.00353	0.00552	CbGbCtD
Pioglitazone—CYP2D6—Dexamethasone—hematologic cancer	0.00346	0.00542	CbGbCtD
Pioglitazone—CYP3A4—Irinotecan—hematologic cancer	0.00334	0.00523	CbGbCtD
Pioglitazone—CYP3A4—Vinblastine—hematologic cancer	0.00297	0.00465	CbGbCtD
Pioglitazone—CYP3A4—Vincristine—hematologic cancer	0.00292	0.00458	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—hematologic cancer	0.00287	0.0045	CbGbCtD
Pioglitazone—CYP3A4—Etoposide—hematologic cancer	0.00268	0.00419	CbGbCtD
Pioglitazone—CYP3A4—Dexamethasone—hematologic cancer	0.0022	0.00345	CbGbCtD
Pioglitazone—CYP3A4—Doxorubicin—hematologic cancer	0.00183	0.00286	CbGbCtD
Pioglitazone—PPARG—Ponatinib—Nilotinib—hematologic cancer	0.00119	0.285	CbGdCrCtD
Pioglitazone—SLCO1B3—lung—hematologic cancer	0.00099	0.083	CbGeAlD
Pioglitazone—SLCO1B1—hematopoietic system—hematologic cancer	0.000986	0.0827	CbGeAlD
Pioglitazone—PPARG—Ponatinib—Imatinib—hematologic cancer	0.000899	0.216	CbGdCrCtD
Pioglitazone—PPARG—Topotecan—Irinotecan—hematologic cancer	0.000852	0.204	CbGdCrCtD
Pioglitazone—PPARG—hematopoietic system—hematologic cancer	0.000851	0.0713	CbGeAlD
Pioglitazone—PPARG—Etoposide—Teniposide—hematologic cancer	0.000846	0.203	CbGdCrCtD
Pioglitazone—SLCO1B1—blood—hematologic cancer	0.000653	0.0548	CbGeAlD
Pioglitazone—CYP2C19—hematopoietic system—hematologic cancer	0.000643	0.0539	CbGeAlD
Pioglitazone—PPARG—blood—hematologic cancer	0.000564	0.0472	CbGeAlD
Pioglitazone—CYP2C8—hematopoietic system—hematologic cancer	0.000561	0.047	CbGeAlD
Pioglitazone—PPARG—bone marrow—hematologic cancer	0.000545	0.0457	CbGeAlD
Pioglitazone—CYP2C9—hematopoietic system—hematologic cancer	0.000498	0.0418	CbGeAlD
Pioglitazone—PPARG—lung—hematologic cancer	0.000494	0.0414	CbGeAlD
Pioglitazone—PPARG—testis—hematologic cancer	0.000466	0.0391	CbGeAlD
Pioglitazone—PTGS1—hematopoietic system—hematologic cancer	0.000455	0.0381	CbGeAlD
Pioglitazone—CYP2C19—blood—hematologic cancer	0.000426	0.0357	CbGeAlD
Pioglitazone—PPARG—Teniposide—Etoposide—hematologic cancer	0.000384	0.0921	CbGdCrCtD
Pioglitazone—CYP3A4—hematopoietic system—hematologic cancer	0.00038	0.0318	CbGeAlD
Pioglitazone—CYP2D6—hematopoietic system—hematologic cancer	0.000374	0.0313	CbGeAlD
Pioglitazone—CYP2C8—blood—hematologic cancer	0.000372	0.0311	CbGeAlD
Pioglitazone—PPARG—lymph node—hematologic cancer	0.000338	0.0283	CbGeAlD
Pioglitazone—CYP2C9—blood—hematologic cancer	0.00033	0.0277	CbGeAlD
Pioglitazone—CYP2C8—testis—hematologic cancer	0.000307	0.0258	CbGeAlD
Pioglitazone—PTGS1—blood—hematologic cancer	0.000301	0.0253	CbGeAlD
Pioglitazone—PTGS1—lung—hematologic cancer	0.000264	0.0221	CbGeAlD
Pioglitazone—CYP3A4—blood—hematologic cancer	0.000252	0.0211	CbGeAlD
Pioglitazone—PTGS1—testis—hematologic cancer	0.000249	0.0209	CbGeAlD
Pioglitazone—CYP2D6—blood—hematologic cancer	0.000248	0.0208	CbGeAlD
Pioglitazone—CYP2D6—testis—hematologic cancer	0.000205	0.0172	CbGeAlD
Pioglitazone—PTGS1—lymph node—hematologic cancer	0.000181	0.0151	CbGeAlD
Pioglitazone—Diarrhoea—Alitretinoin—hematologic cancer	4.68e-05	0.00018	CcSEcCtD
Pioglitazone—Headache—Thiotepa—hematologic cancer	4.66e-05	0.000179	CcSEcCtD
Pioglitazone—Hypertension—Betamethasone—hematologic cancer	4.65e-05	0.000179	CcSEcCtD
Pioglitazone—Hypertension—Dexamethasone—hematologic cancer	4.65e-05	0.000179	CcSEcCtD
Pioglitazone—Diarrhoea—Ifosfamide—hematologic cancer	4.62e-05	0.000178	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Etoposide—hematologic cancer	4.61e-05	0.000177	CcSEcCtD
Pioglitazone—Asthenia—Mitoxantrone—hematologic cancer	4.6e-05	0.000177	CcSEcCtD
Pioglitazone—Asthenia—Irinotecan—hematologic cancer	4.6e-05	0.000177	CcSEcCtD
Pioglitazone—Fatigue—Etoposide—hematologic cancer	4.6e-05	0.000177	CcSEcCtD
Pioglitazone—Myalgia—Betamethasone—hematologic cancer	4.58e-05	0.000176	CcSEcCtD
Pioglitazone—Myalgia—Dexamethasone—hematologic cancer	4.58e-05	0.000176	CcSEcCtD
Pioglitazone—Dizziness—Carmustine—hematologic cancer	4.56e-05	0.000176	CcSEcCtD
Pioglitazone—Urinary tract infection—Epirubicin—hematologic cancer	4.56e-05	0.000176	CcSEcCtD
Pioglitazone—Discomfort—Dexamethasone—hematologic cancer	4.53e-05	0.000174	CcSEcCtD
Pioglitazone—Discomfort—Betamethasone—hematologic cancer	4.53e-05	0.000174	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—hematologic cancer	4.53e-05	0.000174	CcSEcCtD
Pioglitazone—Dizziness—Alitretinoin—hematologic cancer	4.52e-05	0.000174	CcSEcCtD
Pioglitazone—Diarrhoea—Vincristine—hematologic cancer	4.51e-05	0.000174	CcSEcCtD
Pioglitazone—Headache—Thalidomide—hematologic cancer	4.5e-05	0.000173	CcSEcCtD
Pioglitazone—Hepatitis—Methotrexate—hematologic cancer	4.5e-05	0.000173	CcSEcCtD
Pioglitazone—Sweating—Epirubicin—hematologic cancer	4.5e-05	0.000173	CcSEcCtD
Pioglitazone—Asthenia—Gemcitabine—hematologic cancer	4.49e-05	0.000173	CcSEcCtD
Pioglitazone—Haematuria—Epirubicin—hematologic cancer	4.47e-05	0.000172	CcSEcCtD
Pioglitazone—Dizziness—Ifosfamide—hematologic cancer	4.47e-05	0.000172	CcSEcCtD
Pioglitazone—Pharyngitis—Methotrexate—hematologic cancer	4.47e-05	0.000172	CcSEcCtD
Pioglitazone—Urinary tract disorder—Methotrexate—hematologic cancer	4.44e-05	0.000171	CcSEcCtD
Pioglitazone—Weight increased—Doxorubicin—hematologic cancer	4.43e-05	0.000171	CcSEcCtD
Pioglitazone—Urethral disorder—Methotrexate—hematologic cancer	4.41e-05	0.00017	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	4.41e-05	0.00017	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—hematologic cancer	4.4e-05	0.00017	CcSEcCtD
Pioglitazone—Sinusitis—Epirubicin—hematologic cancer	4.4e-05	0.000169	CcSEcCtD
Pioglitazone—Feeling abnormal—Etoposide—hematologic cancer	4.4e-05	0.000169	CcSEcCtD
Pioglitazone—Oedema—Betamethasone—hematologic cancer	4.39e-05	0.000169	CcSEcCtD
Pioglitazone—Anaphylactic shock—Dexamethasone—hematologic cancer	4.39e-05	0.000169	CcSEcCtD
Pioglitazone—Oedema—Dexamethasone—hematologic cancer	4.39e-05	0.000169	CcSEcCtD
Pioglitazone—Anaphylactic shock—Betamethasone—hematologic cancer	4.39e-05	0.000169	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—hematologic cancer	4.39e-05	0.000169	CcSEcCtD
Pioglitazone—Diarrhoea—Mitoxantrone—hematologic cancer	4.39e-05	0.000169	CcSEcCtD
Pioglitazone—Diarrhoea—Irinotecan—hematologic cancer	4.39e-05	0.000169	CcSEcCtD
Pioglitazone—Insomnia—Triamcinolone—hematologic cancer	4.38e-05	0.000169	CcSEcCtD
Pioglitazone—Infection—Dexamethasone—hematologic cancer	4.36e-05	0.000168	CcSEcCtD
Pioglitazone—Infection—Betamethasone—hematologic cancer	4.36e-05	0.000168	CcSEcCtD
Pioglitazone—Dizziness—Vincristine—hematologic cancer	4.36e-05	0.000168	CcSEcCtD
Pioglitazone—Ill-defined disorder—Prednisone—hematologic cancer	4.35e-05	0.000167	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—hematologic cancer	4.34e-05	0.000167	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—hematologic cancer	4.34e-05	0.000167	CcSEcCtD
Pioglitazone—Feeling abnormal—Prednisolone—hematologic cancer	4.34e-05	0.000167	CcSEcCtD
Pioglitazone—Visual impairment—Methotrexate—hematologic cancer	4.34e-05	0.000167	CcSEcCtD
Pioglitazone—Anaemia—Prednisone—hematologic cancer	4.33e-05	0.000167	CcSEcCtD
Pioglitazone—Headache—Carmustine—hematologic cancer	4.32e-05	0.000167	CcSEcCtD
Pioglitazone—Dyspnoea—Triamcinolone—hematologic cancer	4.32e-05	0.000166	CcSEcCtD
Pioglitazone—Nervous system disorder—Dexamethasone—hematologic cancer	4.31e-05	0.000166	CcSEcCtD
Pioglitazone—Nervous system disorder—Betamethasone—hematologic cancer	4.31e-05	0.000166	CcSEcCtD
Pioglitazone—Hypersensitivity—Cisplatin—hematologic cancer	4.29e-05	0.000165	CcSEcCtD
Pioglitazone—Headache—Alitretinoin—hematologic cancer	4.28e-05	0.000165	CcSEcCtD
Pioglitazone—Angioedema—Prednisone—hematologic cancer	4.28e-05	0.000165	CcSEcCtD
Pioglitazone—Diarrhoea—Gemcitabine—hematologic cancer	4.28e-05	0.000165	CcSEcCtD
Pioglitazone—Hyperhidrosis—Betamethasone—hematologic cancer	4.25e-05	0.000164	CcSEcCtD
Pioglitazone—Hyperhidrosis—Dexamethasone—hematologic cancer	4.25e-05	0.000164	CcSEcCtD
Pioglitazone—Dizziness—Irinotecan—hematologic cancer	4.24e-05	0.000163	CcSEcCtD
Pioglitazone—Urticaria—Etoposide—hematologic cancer	4.24e-05	0.000163	CcSEcCtD
Pioglitazone—Malaise—Prednisone—hematologic cancer	4.23e-05	0.000163	CcSEcCtD
Pioglitazone—Urinary tract infection—Doxorubicin—hematologic cancer	4.22e-05	0.000162	CcSEcCtD
Pioglitazone—Vertigo—Prednisone—hematologic cancer	4.21e-05	0.000162	CcSEcCtD
Pioglitazone—Hepatitis—Epirubicin—hematologic cancer	4.21e-05	0.000162	CcSEcCtD
Pioglitazone—Eye disorder—Methotrexate—hematologic cancer	4.21e-05	0.000162	CcSEcCtD
Pioglitazone—Hypoaesthesia—Epirubicin—hematologic cancer	4.19e-05	0.000161	CcSEcCtD
Pioglitazone—Urticaria—Prednisolone—hematologic cancer	4.18e-05	0.000161	CcSEcCtD
Pioglitazone—Asthenia—Cisplatin—hematologic cancer	4.18e-05	0.000161	CcSEcCtD
Pioglitazone—Pharyngitis—Epirubicin—hematologic cancer	4.18e-05	0.000161	CcSEcCtD
Pioglitazone—Cardiac disorder—Methotrexate—hematologic cancer	4.18e-05	0.000161	CcSEcCtD
Pioglitazone—Fatigue—Triamcinolone—hematologic cancer	4.17e-05	0.000161	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—hematologic cancer	4.16e-05	0.00016	CcSEcCtD
Pioglitazone—Urinary tract disorder—Epirubicin—hematologic cancer	4.16e-05	0.00016	CcSEcCtD
Pioglitazone—Oedema peripheral—Epirubicin—hematologic cancer	4.15e-05	0.00016	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—hematologic cancer	4.14e-05	0.000159	CcSEcCtD
Pioglitazone—Connective tissue disorder—Epirubicin—hematologic cancer	4.14e-05	0.000159	CcSEcCtD
Pioglitazone—Urethral disorder—Epirubicin—hematologic cancer	4.13e-05	0.000159	CcSEcCtD
Pioglitazone—Headache—Vincristine—hematologic cancer	4.13e-05	0.000159	CcSEcCtD
Pioglitazone—Sinusitis—Doxorubicin—hematologic cancer	4.07e-05	0.000157	CcSEcCtD
Pioglitazone—Immune system disorder—Methotrexate—hematologic cancer	4.07e-05	0.000157	CcSEcCtD
Pioglitazone—Visual impairment—Epirubicin—hematologic cancer	4.06e-05	0.000156	CcSEcCtD
Pioglitazone—Mediastinal disorder—Methotrexate—hematologic cancer	4.06e-05	0.000156	CcSEcCtD
Pioglitazone—Hypertension—Prednisone—hematologic cancer	4.05e-05	0.000156	CcSEcCtD
Pioglitazone—Headache—Irinotecan—hematologic cancer	4.02e-05	0.000155	CcSEcCtD
Pioglitazone—Headache—Mitoxantrone—hematologic cancer	4.02e-05	0.000155	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	4e-05	0.000154	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	4e-05	0.000154	CcSEcCtD
Pioglitazone—Myalgia—Prednisone—hematologic cancer	3.99e-05	0.000154	CcSEcCtD
Pioglitazone—Arthralgia—Prednisone—hematologic cancer	3.99e-05	0.000154	CcSEcCtD
Pioglitazone—Feeling abnormal—Triamcinolone—hematologic cancer	3.99e-05	0.000154	CcSEcCtD
Pioglitazone—Diarrhoea—Cisplatin—hematologic cancer	3.99e-05	0.000154	CcSEcCtD
Pioglitazone—Insomnia—Dexamethasone—hematologic cancer	3.97e-05	0.000153	CcSEcCtD
Pioglitazone—Insomnia—Betamethasone—hematologic cancer	3.97e-05	0.000153	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.96e-05	0.000153	CcSEcCtD
Pioglitazone—Discomfort—Prednisone—hematologic cancer	3.94e-05	0.000152	CcSEcCtD
Pioglitazone—Eye disorder—Epirubicin—hematologic cancer	3.94e-05	0.000152	CcSEcCtD
Pioglitazone—Hypersensitivity—Etoposide—hematologic cancer	3.93e-05	0.000151	CcSEcCtD
Pioglitazone—Malnutrition—Methotrexate—hematologic cancer	3.92e-05	0.000151	CcSEcCtD
Pioglitazone—Headache—Gemcitabine—hematologic cancer	3.92e-05	0.000151	CcSEcCtD
Pioglitazone—Cardiac disorder—Epirubicin—hematologic cancer	3.91e-05	0.000151	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—hematologic cancer	3.9e-05	0.00015	CcSEcCtD
Pioglitazone—Hypersensitivity—Prednisolone—hematologic cancer	3.88e-05	0.000149	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—hematologic cancer	3.88e-05	0.000149	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—hematologic cancer	3.87e-05	0.000149	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—hematologic cancer	3.85e-05	0.000148	CcSEcCtD
Pioglitazone—Urticaria—Triamcinolone—hematologic cancer	3.85e-05	0.000148	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—hematologic cancer	3.84e-05	0.000148	CcSEcCtD
Pioglitazone—Asthenia—Etoposide—hematologic cancer	3.83e-05	0.000147	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—hematologic cancer	3.83e-05	0.000147	CcSEcCtD
Pioglitazone—Oedema—Prednisone—hematologic cancer	3.83e-05	0.000147	CcSEcCtD
Pioglitazone—Anaphylactic shock—Prednisone—hematologic cancer	3.83e-05	0.000147	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—hematologic cancer	3.82e-05	0.000147	CcSEcCtD
Pioglitazone—Immune system disorder—Epirubicin—hematologic cancer	3.8e-05	0.000146	CcSEcCtD
Pioglitazone—Infection—Prednisone—hematologic cancer	3.8e-05	0.000146	CcSEcCtD
Pioglitazone—Mediastinal disorder—Epirubicin—hematologic cancer	3.8e-05	0.000146	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.79e-05	0.000146	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.79e-05	0.000146	CcSEcCtD
Pioglitazone—Back pain—Methotrexate—hematologic cancer	3.79e-05	0.000146	CcSEcCtD
Pioglitazone—Fatigue—Betamethasone—hematologic cancer	3.79e-05	0.000146	CcSEcCtD
Pioglitazone—Fatigue—Dexamethasone—hematologic cancer	3.79e-05	0.000146	CcSEcCtD
Pioglitazone—Visual impairment—Doxorubicin—hematologic cancer	3.76e-05	0.000145	CcSEcCtD
Pioglitazone—Nervous system disorder—Prednisone—hematologic cancer	3.75e-05	0.000144	CcSEcCtD
Pioglitazone—Skin disorder—Prednisone—hematologic cancer	3.72e-05	0.000143	CcSEcCtD
Pioglitazone—Hyperhidrosis—Prednisone—hematologic cancer	3.7e-05	0.000142	CcSEcCtD
Pioglitazone—Malnutrition—Epirubicin—hematologic cancer	3.67e-05	0.000141	CcSEcCtD
Pioglitazone—Diarrhoea—Etoposide—hematologic cancer	3.65e-05	0.000141	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—hematologic cancer	3.64e-05	0.00014	CcSEcCtD
Pioglitazone—Ill-defined disorder—Methotrexate—hematologic cancer	3.64e-05	0.00014	CcSEcCtD
Pioglitazone—Anaemia—Methotrexate—hematologic cancer	3.62e-05	0.000139	CcSEcCtD
Pioglitazone—Feeling abnormal—Dexamethasone—hematologic cancer	3.62e-05	0.000139	CcSEcCtD
Pioglitazone—Feeling abnormal—Betamethasone—hematologic cancer	3.62e-05	0.000139	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—hematologic cancer	3.62e-05	0.000139	CcSEcCtD
Pioglitazone—Flatulence—Epirubicin—hematologic cancer	3.61e-05	0.000139	CcSEcCtD
Pioglitazone—Hypersensitivity—Triamcinolone—hematologic cancer	3.57e-05	0.000137	CcSEcCtD
Pioglitazone—Back pain—Epirubicin—hematologic cancer	3.55e-05	0.000137	CcSEcCtD
Pioglitazone—Malaise—Methotrexate—hematologic cancer	3.53e-05	0.000136	CcSEcCtD
Pioglitazone—Dizziness—Etoposide—hematologic cancer	3.53e-05	0.000136	CcSEcCtD
Pioglitazone—Muscle spasms—Epirubicin—hematologic cancer	3.53e-05	0.000136	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—hematologic cancer	3.52e-05	0.000136	CcSEcCtD
Pioglitazone—Vertigo—Methotrexate—hematologic cancer	3.52e-05	0.000136	CcSEcCtD
Pioglitazone—Mediastinal disorder—Doxorubicin—hematologic cancer	3.51e-05	0.000135	CcSEcCtD
Pioglitazone—Urticaria—Dexamethasone—hematologic cancer	3.49e-05	0.000134	CcSEcCtD
Pioglitazone—Urticaria—Betamethasone—hematologic cancer	3.49e-05	0.000134	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Prednisone—hematologic cancer	3.49e-05	0.000134	CcSEcCtD
Pioglitazone—Dizziness—Prednisolone—hematologic cancer	3.48e-05	0.000134	CcSEcCtD
Pioglitazone—Asthenia—Triamcinolone—hematologic cancer	3.47e-05	0.000134	CcSEcCtD
Pioglitazone—Insomnia—Prednisone—hematologic cancer	3.46e-05	0.000133	CcSEcCtD
Pioglitazone—Ill-defined disorder—Epirubicin—hematologic cancer	3.4e-05	0.000131	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—hematologic cancer	3.39e-05	0.000131	CcSEcCtD
Pioglitazone—Anaemia—Epirubicin—hematologic cancer	3.39e-05	0.00013	CcSEcCtD
Pioglitazone—Headache—Etoposide—hematologic cancer	3.34e-05	0.000129	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—hematologic cancer	3.34e-05	0.000129	CcSEcCtD
Pioglitazone—Myalgia—Methotrexate—hematologic cancer	3.34e-05	0.000128	CcSEcCtD
Pioglitazone—Chest pain—Methotrexate—hematologic cancer	3.34e-05	0.000128	CcSEcCtD
Pioglitazone—Arthralgia—Methotrexate—hematologic cancer	3.34e-05	0.000128	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	3.31e-05	0.000128	CcSEcCtD
Pioglitazone—Malaise—Epirubicin—hematologic cancer	3.31e-05	0.000127	CcSEcCtD
Pioglitazone—Fatigue—Prednisone—hematologic cancer	3.3e-05	0.000127	CcSEcCtD
Pioglitazone—Headache—Prednisolone—hematologic cancer	3.3e-05	0.000127	CcSEcCtD
Pioglitazone—Discomfort—Methotrexate—hematologic cancer	3.3e-05	0.000127	CcSEcCtD
Pioglitazone—Vertigo—Epirubicin—hematologic cancer	3.29e-05	0.000127	CcSEcCtD
Pioglitazone—Back pain—Doxorubicin—hematologic cancer	3.28e-05	0.000126	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—hematologic cancer	3.26e-05	0.000126	CcSEcCtD
Pioglitazone—Dizziness—Triamcinolone—hematologic cancer	3.2e-05	0.000123	CcSEcCtD
Pioglitazone—Anaphylactic shock—Methotrexate—hematologic cancer	3.2e-05	0.000123	CcSEcCtD
Pioglitazone—Infection—Methotrexate—hematologic cancer	3.18e-05	0.000122	CcSEcCtD
Pioglitazone—Hypertension—Epirubicin—hematologic cancer	3.17e-05	0.000122	CcSEcCtD
Pioglitazone—Feeling abnormal—Prednisone—hematologic cancer	3.15e-05	0.000121	CcSEcCtD
Pioglitazone—Asthenia—Dexamethasone—hematologic cancer	3.15e-05	0.000121	CcSEcCtD
Pioglitazone—Asthenia—Betamethasone—hematologic cancer	3.15e-05	0.000121	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—hematologic cancer	3.15e-05	0.000121	CcSEcCtD
Pioglitazone—Nervous system disorder—Methotrexate—hematologic cancer	3.14e-05	0.000121	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—hematologic cancer	3.14e-05	0.000121	CcSEcCtD
Pioglitazone—Myalgia—Epirubicin—hematologic cancer	3.12e-05	0.00012	CcSEcCtD
Pioglitazone—Chest pain—Epirubicin—hematologic cancer	3.12e-05	0.00012	CcSEcCtD
Pioglitazone—Arthralgia—Epirubicin—hematologic cancer	3.12e-05	0.00012	CcSEcCtD
Pioglitazone—Skin disorder—Methotrexate—hematologic cancer	3.11e-05	0.00012	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	3.1e-05	0.000119	CcSEcCtD
Pioglitazone—Hyperhidrosis—Methotrexate—hematologic cancer	3.09e-05	0.000119	CcSEcCtD
Pioglitazone—Discomfort—Epirubicin—hematologic cancer	3.08e-05	0.000119	CcSEcCtD
Pioglitazone—Malaise—Doxorubicin—hematologic cancer	3.06e-05	0.000118	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—hematologic cancer	3.05e-05	0.000117	CcSEcCtD
Pioglitazone—Urticaria—Prednisone—hematologic cancer	3.04e-05	0.000117	CcSEcCtD
Pioglitazone—Headache—Triamcinolone—hematologic cancer	3.03e-05	0.000117	CcSEcCtD
Pioglitazone—Diarrhoea—Dexamethasone—hematologic cancer	3.01e-05	0.000116	CcSEcCtD
Pioglitazone—Diarrhoea—Betamethasone—hematologic cancer	3.01e-05	0.000116	CcSEcCtD
Pioglitazone—Anaphylactic shock—Epirubicin—hematologic cancer	2.99e-05	0.000115	CcSEcCtD
Pioglitazone—Oedema—Epirubicin—hematologic cancer	2.99e-05	0.000115	CcSEcCtD
Pioglitazone—Infection—Epirubicin—hematologic cancer	2.97e-05	0.000114	CcSEcCtD
Pioglitazone—Nervous system disorder—Epirubicin—hematologic cancer	2.93e-05	0.000113	CcSEcCtD
Pioglitazone—Hypertension—Doxorubicin—hematologic cancer	2.93e-05	0.000113	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.91e-05	0.000112	CcSEcCtD
Pioglitazone—Skin disorder—Epirubicin—hematologic cancer	2.91e-05	0.000112	CcSEcCtD
Pioglitazone—Dizziness—Dexamethasone—hematologic cancer	2.91e-05	0.000112	CcSEcCtD
Pioglitazone—Dizziness—Betamethasone—hematologic cancer	2.91e-05	0.000112	CcSEcCtD
Pioglitazone—Hyperhidrosis—Epirubicin—hematologic cancer	2.89e-05	0.000111	CcSEcCtD
Pioglitazone—Insomnia—Methotrexate—hematologic cancer	2.89e-05	0.000111	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—hematologic cancer	2.89e-05	0.000111	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—hematologic cancer	2.89e-05	0.000111	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—hematologic cancer	2.89e-05	0.000111	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.87e-05	0.00011	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—hematologic cancer	2.85e-05	0.00011	CcSEcCtD
Pioglitazone—Dyspnoea—Methotrexate—hematologic cancer	2.85e-05	0.00011	CcSEcCtD
Pioglitazone—Hypersensitivity—Prednisone—hematologic cancer	2.82e-05	0.000109	CcSEcCtD
Pioglitazone—Oedema—Doxorubicin—hematologic cancer	2.77e-05	0.000107	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—hematologic cancer	2.77e-05	0.000107	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.76e-05	0.000106	CcSEcCtD
Pioglitazone—Fatigue—Methotrexate—hematologic cancer	2.76e-05	0.000106	CcSEcCtD
Pioglitazone—Headache—Betamethasone—hematologic cancer	2.75e-05	0.000106	CcSEcCtD
Pioglitazone—Headache—Dexamethasone—hematologic cancer	2.75e-05	0.000106	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—hematologic cancer	2.75e-05	0.000106	CcSEcCtD
Pioglitazone—Asthenia—Prednisone—hematologic cancer	2.75e-05	0.000106	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.73e-05	0.000105	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—hematologic cancer	2.72e-05	0.000105	CcSEcCtD
Pioglitazone—Insomnia—Epirubicin—hematologic cancer	2.71e-05	0.000104	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—hematologic cancer	2.69e-05	0.000104	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—hematologic cancer	2.68e-05	0.000103	CcSEcCtD
Pioglitazone—Dyspnoea—Epirubicin—hematologic cancer	2.67e-05	0.000103	CcSEcCtD
Pioglitazone—Feeling abnormal—Methotrexate—hematologic cancer	2.63e-05	0.000101	CcSEcCtD
Pioglitazone—Diarrhoea—Prednisone—hematologic cancer	2.62e-05	0.000101	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.58e-05	9.95e-05	CcSEcCtD
Pioglitazone—Fatigue—Epirubicin—hematologic cancer	2.58e-05	9.93e-05	CcSEcCtD
Pioglitazone—Urticaria—Methotrexate—hematologic cancer	2.54e-05	9.78e-05	CcSEcCtD
Pioglitazone—Dizziness—Prednisone—hematologic cancer	2.53e-05	9.74e-05	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	2.52e-05	9.71e-05	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—hematologic cancer	2.5e-05	9.64e-05	CcSEcCtD
Pioglitazone—Dyspnoea—Doxorubicin—hematologic cancer	2.47e-05	9.5e-05	CcSEcCtD
Pioglitazone—Feeling abnormal—Epirubicin—hematologic cancer	2.47e-05	9.49e-05	CcSEcCtD
Pioglitazone—Headache—Prednisone—hematologic cancer	2.4e-05	9.23e-05	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	2.39e-05	9.2e-05	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—hematologic cancer	2.39e-05	9.19e-05	CcSEcCtD
Pioglitazone—Urticaria—Epirubicin—hematologic cancer	2.38e-05	9.15e-05	CcSEcCtD
Pioglitazone—Hypersensitivity—Methotrexate—hematologic cancer	2.36e-05	9.07e-05	CcSEcCtD
Pioglitazone—Asthenia—Methotrexate—hematologic cancer	2.29e-05	8.83e-05	CcSEcCtD
Pioglitazone—Feeling abnormal—Doxorubicin—hematologic cancer	2.28e-05	8.78e-05	CcSEcCtD
Pioglitazone—Hypersensitivity—Epirubicin—hematologic cancer	2.2e-05	8.49e-05	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—hematologic cancer	2.2e-05	8.47e-05	CcSEcCtD
Pioglitazone—Diarrhoea—Methotrexate—hematologic cancer	2.19e-05	8.42e-05	CcSEcCtD
Pioglitazone—Asthenia—Epirubicin—hematologic cancer	2.15e-05	8.27e-05	CcSEcCtD
Pioglitazone—Dizziness—Methotrexate—hematologic cancer	2.11e-05	8.14e-05	CcSEcCtD
Pioglitazone—Diarrhoea—Epirubicin—hematologic cancer	2.05e-05	7.88e-05	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—hematologic cancer	2.04e-05	7.85e-05	CcSEcCtD
Pioglitazone—Headache—Methotrexate—hematologic cancer	2e-05	7.71e-05	CcSEcCtD
Pioglitazone—Asthenia—Doxorubicin—hematologic cancer	1.99e-05	7.65e-05	CcSEcCtD
Pioglitazone—Dizziness—Epirubicin—hematologic cancer	1.98e-05	7.62e-05	CcSEcCtD
Pioglitazone—Diarrhoea—Doxorubicin—hematologic cancer	1.89e-05	7.29e-05	CcSEcCtD
Pioglitazone—Headache—Epirubicin—hematologic cancer	1.87e-05	7.22e-05	CcSEcCtD
Pioglitazone—Dizziness—Doxorubicin—hematologic cancer	1.83e-05	7.05e-05	CcSEcCtD
Pioglitazone—Headache—Doxorubicin—hematologic cancer	1.73e-05	6.68e-05	CcSEcCtD
Pioglitazone—SLCO1B3—Metabolism—ALB—hematologic cancer	8.02e-06	9.37e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	8.01e-06	9.36e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—IDH1—hematologic cancer	8.01e-06	9.35e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCC3—hematologic cancer	7.99e-06	9.33e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTO1—hematologic cancer	7.99e-06	9.33e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TXN—hematologic cancer	7.99e-06	9.33e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC22A1—hematologic cancer	7.94e-06	9.28e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CRABP1—hematologic cancer	7.94e-06	9.28e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—MTR—hematologic cancer	7.93e-06	9.26e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ABCG2—hematologic cancer	7.93e-06	9.26e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTO1—hematologic cancer	7.92e-06	9.25e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCC3—hematologic cancer	7.92e-06	9.25e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TXN—hematologic cancer	7.92e-06	9.25e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CG—hematologic cancer	7.88e-06	9.21e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	7.83e-06	9.15e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SPHK1—hematologic cancer	7.81e-06	9.13e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ENO2—hematologic cancer	7.78e-06	9.09e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SPHK1—hematologic cancer	7.75e-06	9.05e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALOX5—hematologic cancer	7.74e-06	9.04e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3R1—hematologic cancer	7.67e-06	8.96e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ABCB1—hematologic cancer	7.66e-06	8.95e-05	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—AKT1—hematologic cancer	7.56e-06	8.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTT1—hematologic cancer	7.54e-06	8.81e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—UGT1A1—hematologic cancer	7.51e-06	8.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NUP98—hematologic cancer	7.49e-06	8.76e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—UGT1A1—hematologic cancer	7.44e-06	8.7e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—NCOR1—hematologic cancer	7.44e-06	8.69e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—GSTM1—hematologic cancer	7.44e-06	8.69e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.43e-06	8.68e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTAP—hematologic cancer	7.41e-06	8.66e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—MTHFR—hematologic cancer	7.39e-06	8.63e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SDC1—hematologic cancer	7.37e-06	8.61e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CREBBP—hematologic cancer	7.31e-06	8.54e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CRABP1—hematologic cancer	7.3e-06	8.53e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC22A1—hematologic cancer	7.3e-06	8.53e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ADCY7—hematologic cancer	7.28e-06	8.5e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NCOA3—hematologic cancer	7.28e-06	8.5e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC22A1—hematologic cancer	7.24e-06	8.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CRABP1—hematologic cancer	7.24e-06	8.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NUP214—hematologic cancer	7.22e-06	8.44e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.15e-06	8.35e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALOX5—hematologic cancer	7.12e-06	8.32e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CB—hematologic cancer	7.08e-06	8.27e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—MTR—hematologic cancer	7.08e-06	8.27e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ABCG2—hematologic cancer	7.08e-06	8.27e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALOX5—hematologic cancer	7.06e-06	8.24e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.04e-06	8.23e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.95e-06	8.12e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ENO2—hematologic cancer	6.94e-06	8.11e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CD—hematologic cancer	6.93e-06	8.1e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NUP98—hematologic cancer	6.89e-06	8.05e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ALB—hematologic cancer	6.84e-06	7.99e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NUP98—hematologic cancer	6.83e-06	7.98e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTT1—hematologic cancer	6.73e-06	7.87e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ADCY7—hematologic cancer	6.69e-06	7.82e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NCOA3—hematologic cancer	6.69e-06	7.82e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.65e-06	7.77e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NUP214—hematologic cancer	6.64e-06	7.76e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ADCY7—hematologic cancer	6.63e-06	7.75e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NCOA3—hematologic cancer	6.63e-06	7.75e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.63e-06	7.74e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—FHL2—hematologic cancer	6.61e-06	7.72e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NUP214—hematologic cancer	6.59e-06	7.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SDC1—hematologic cancer	6.58e-06	7.69e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—MTHFR—hematologic cancer	6.57e-06	7.68e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3R1—hematologic cancer	6.54e-06	7.65e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	6.52e-06	7.62e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.51e-06	7.61e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCG2—hematologic cancer	6.51e-06	7.61e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MTR—hematologic cancer	6.51e-06	7.61e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AGRN—hematologic cancer	6.48e-06	7.57e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCG2—hematologic cancer	6.45e-06	7.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MTR—hematologic cancer	6.45e-06	7.54e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ENO2—hematologic cancer	6.38e-06	7.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ENO2—hematologic cancer	6.33e-06	7.39e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.29e-06	7.34e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CD44—hematologic cancer	6.27e-06	7.32e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NQO1—hematologic cancer	6.27e-06	7.32e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	6.21e-06	7.25e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.2e-06	7.25e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTT1—hematologic cancer	6.19e-06	7.23e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HMMR—hematologic cancer	6.14e-06	7.17e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—IDH2—hematologic cancer	6.14e-06	7.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.14e-06	7.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.14e-06	7.17e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTEN—hematologic cancer	6.12e-06	7.15e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SDC1—hematologic cancer	6.05e-06	7.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.04e-06	7.06e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CB—hematologic cancer	6.04e-06	7.06e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SDC1—hematologic cancer	6e-06	7.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.94e-06	6.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYCS—hematologic cancer	5.93e-06	6.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	5.89e-06	6.89e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—EP300—hematologic cancer	5.83e-06	6.82e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.79e-06	6.77e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ARNTL—hematologic cancer	5.77e-06	6.75e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CREBBP—hematologic cancer	5.76e-06	6.72e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MAPK3—hematologic cancer	5.74e-06	6.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.73e-06	6.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.66e-06	6.61e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ACP5—hematologic cancer	5.62e-06	6.56e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CA9—hematologic cancer	5.62e-06	6.56e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CD44—hematologic cancer	5.59e-06	6.54e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NQO1—hematologic cancer	5.59e-06	6.54e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MYC—hematologic cancer	5.58e-06	6.52e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NCOR2—hematologic cancer	5.54e-06	6.48e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CG—hematologic cancer	5.52e-06	6.45e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.48e-06	6.4e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	5.46e-06	6.38e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.41e-06	6.32e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ALB—hematologic cancer	5.39e-06	6.29e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.3e-06	6.2e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYCS—hematologic cancer	5.29e-06	6.19e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—IDH1—hematologic cancer	5.28e-06	6.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.26e-06	6.15e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTP1—hematologic cancer	5.23e-06	6.11e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.22e-06	6.1e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TXN—hematologic cancer	5.22e-06	6.1e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.22e-06	6.1e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTEN—hematologic cancer	5.22e-06	6.1e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	5.15e-06	6.02e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CD44—hematologic cancer	5.15e-06	6.01e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NQO1—hematologic cancer	5.15e-06	6.01e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CREBBP—hematologic cancer	5.12e-06	5.98e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.11e-06	5.97e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NQO1—hematologic cancer	5.1e-06	5.96e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CD44—hematologic cancer	5.1e-06	5.96e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.06e-06	5.91e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5e-06	5.84e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—EP300—hematologic cancer	4.98e-06	5.82e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ABCB1—hematologic cancer	4.95e-06	5.78e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	4.91e-06	5.74e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYCS—hematologic cancer	4.87e-06	5.69e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CD—hematologic cancer	4.86e-06	5.67e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	4.84e-06	5.65e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYCS—hematologic cancer	4.83e-06	5.64e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NCOR1—hematologic cancer	4.8e-06	5.61e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—GSTM1—hematologic cancer	4.8e-06	5.61e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	4.8e-06	5.6e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ALB—hematologic cancer	4.79e-06	5.6e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	4.78e-06	5.58e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CRABP1—hematologic cancer	4.78e-06	5.58e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	4.76e-06	5.56e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.73e-06	5.53e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTP1—hematologic cancer	4.67e-06	5.45e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALOX5—hematologic cancer	4.65e-06	5.44e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3R1—hematologic cancer	4.58e-06	5.36e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.51e-06	5.27e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NUP98—hematologic cancer	4.51e-06	5.27e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.42e-06	5.16e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.38e-06	5.11e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.38e-06	5.11e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NUP214—hematologic cancer	4.34e-06	5.08e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.32e-06	5.04e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CA—hematologic cancer	4.32e-06	5.04e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTP1—hematologic cancer	4.29e-06	5.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.29e-06	5.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.29e-06	5.01e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.26e-06	4.97e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTR—hematologic cancer	4.26e-06	4.97e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.25e-06	4.97e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—MTHFR—hematologic cancer	4.25e-06	4.96e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CB—hematologic cancer	4.23e-06	4.94e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ENO2—hematologic cancer	4.17e-06	4.88e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.12e-06	4.81e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTEN—hematologic cancer	4.11e-06	4.8e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCB1—hematologic cancer	4.06e-06	4.75e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.05e-06	4.73e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.03e-06	4.71e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SDC1—hematologic cancer	3.96e-06	4.62e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—GSTM1—hematologic cancer	3.94e-06	4.61e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NCOR1—hematologic cancer	3.94e-06	4.61e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—EP300—hematologic cancer	3.92e-06	4.58e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NCOR1—hematologic cancer	3.91e-06	4.57e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—GSTM1—hematologic cancer	3.91e-06	4.57e-05	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—hematologic cancer	3.87e-06	4.52e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—MTHFR—hematologic cancer	3.79e-06	4.43e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.74e-06	4.37e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CA—hematologic cancer	3.68e-06	4.3e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTEN—hematologic cancer	3.66e-06	4.27e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CG—hematologic cancer	3.57e-06	4.17e-05	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—hematologic cancer	3.53e-06	4.12e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—EP300—hematologic cancer	3.49e-06	4.07e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—MTHFR—hematologic cancer	3.49e-06	4.07e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.46e-06	4.04e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NQO1—hematologic cancer	3.36e-06	3.93e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CD44—hematologic cancer	3.36e-06	3.93e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.34e-06	3.9e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CREBBP—hematologic cancer	3.31e-06	3.86e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.18e-06	3.72e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYCS—hematologic cancer	3.18e-06	3.72e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.16e-06	3.7e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CD—hematologic cancer	3.14e-06	3.66e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ALB—hematologic cancer	3.1e-06	3.62e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.05e-06	3.56e-05	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—hematologic cancer	3.01e-06	3.51e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.96e-06	3.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.95e-06	3.45e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.93e-06	3.42e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.9e-06	3.39e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	2.9e-06	3.39e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.81e-06	3.28e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.8e-06	3.27e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ALB—hematologic cancer	2.76e-06	3.23e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CB—hematologic cancer	2.73e-06	3.19e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.72e-06	3.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.69e-06	3.14e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.66e-06	3.1e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.64e-06	3.09e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CA—hematologic cancer	2.58e-06	3.01e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.58e-06	3.01e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.58e-06	3.01e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	2.57e-06	3.01e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.55e-06	2.98e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ALB—hematologic cancer	2.54e-06	2.97e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ALB—hematologic cancer	2.52e-06	2.94e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.44e-06	2.85e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	2.43e-06	2.84e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.41e-06	2.82e-05	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—hematologic cancer	2.37e-06	2.77e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTEN—hematologic cancer	2.36e-06	2.76e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.28e-06	2.66e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—EP300—hematologic cancer	2.25e-06	2.63e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	2.24e-06	2.62e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.22e-06	2.6e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTEN—hematologic cancer	2.11e-06	2.46e-05	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—hematologic cancer	2.11e-06	2.46e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—EP300—hematologic cancer	2.01e-06	2.35e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTEN—hematologic cancer	1.94e-06	2.27e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTEN—hematologic cancer	1.92e-06	2.25e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.91e-06	2.24e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—EP300—hematologic cancer	1.85e-06	2.16e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—EP300—hematologic cancer	1.83e-06	2.14e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.78e-06	2.07e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.68e-06	1.97e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.67e-06	1.95e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ALB—hematologic cancer	1.66e-06	1.94e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.59e-06	1.86e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.49e-06	1.74e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.47e-06	1.71e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.37e-06	1.6e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—hematologic cancer	1.36e-06	1.59e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.36e-06	1.58e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTEN—hematologic cancer	1.27e-06	1.48e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—hematologic cancer	1.22e-06	1.42e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—EP300—hematologic cancer	1.21e-06	1.41e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—hematologic cancer	1.12e-06	1.31e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—hematologic cancer	1.11e-06	1.29e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	8.94e-07	1.04e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—hematologic cancer	7.31e-07	8.54e-06	CbGpPWpGaD
